Pharmacokinetic Analysis of β-Glucan After Administration of PGG-Glucan, a Novel Immunomodulator Being Developed for the Treatment of Non-Small Cell Lung Cancer
0 comments.
Click here to read/write comments.
Topics:
Certara is the leading drug development consultancy with solutions spanning the discovery, preclinical and clinical stages of drug development.
Twenty four hour ammonia profiles and correlates of drug effect were examined in a phase 2 comparison of sodium phenylbutyrate (NaPBA) and glycerol phenylbutyrate (GPB or HPN-100), an investigational drug being developed for urea cycle disorders (UCDs). Study Design: Protocol HPN-100-005 involved open label fixed-sequence switch-over from the prescribed NaPBA dose to a PBA-equimolar GPB […]
Read More